Hindering cancer cell growth by targeting annexin-A1. : comp

MDX-124, targeting annexin-A1, shows efficacy in cancer, per Oncogene study in Nature.

Related Keywords

Sussex , East Sussex , United Kingdom , Chris Parris , Fiona Dempsey , Dr Hussein Al Ali At Anglia Ruskin University , Sussex Medical School , Professor Chris Parris , Anglia Ruskin University , Professor Chris Pepper , Life Sciences , Scientific Operations , Newswise , Nnexin Cancer Therapy , Cancer , Cell Biology , All Journal News ,